New anti-obesity pills threaten Eli Lilly and Novo Nordisk’s stock market empire
As more pharmaceutical companies make inroads in the weight loss market, the two firms saw their shares fall more than 10% in the last month
As more pharmaceutical companies make inroads in the weight loss market, the two firms saw their shares fall more than 10% in the last month
This is the second attempt at a tie-up between both Spanish lenders in a market that has gone through several waves of consolidation since the global crisis of 2008
In the last few years, the three funds have jockeyed into privileged positions in listed Spanish banks